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Abstract
Introduction: Hepatic artery aneurysms remain a clinically significant entity. Their incidence
continues to rise slowly and mortality from spontaneous rupture is high. Repair is recommended
in those aneurysms greater than 2 cm in diameter. It is not surprising that vascular comorbidities,
such as ischaemic heart disease, are common in surgical patients, particularly those with arterial
aneurysms such as these. The decision of when to operate on patients who require urgent surgery
despite having recently suffered an acute coronary syndrome remains somewhat of a grey and
controversial area. We discuss the role of delayed surgery and postoperative followup of this
vascular problem.
Case presentation: A 58-year-old man was admitted with a 5.5 cm hepatic artery aneurysm. The
aneurysm was asymptomatic and was an incidental finding as a result of an abdominal computed
tomography scan to investigate an episode of haemoptysis (Figure 1). Three weeks prior to
admission, the patient had suffered a large inferior myocardial infarction and was treated by
thrombolysis and primary coronary angioplasty. Angiographic assessment revealed a large
aneurysm of the common hepatic artery involving the origins of the hepatic, gastroduodenal, left
and right gastric arteries and the splenic artery (Figures 2 and 3). Endovascular treatment was not
considered feasible and immediate surgery was too high-risk in the early post-infarction period.
Therefore, surgery was delayed for 3 months when aneurysm repair with reconstruction of the
hepatic artery was successfully performed. Graft patency was confirmed with the aid of an
abdominal arterial duplex. Plasma levels of conventional liver function enzymes and of alpha-
glutathione-S-transferase were within normal limits. This was used to assess the extent of any
hepatocellular damage perioperatively. The patient made a good recovery and was well at his
routine outpatient check-ups.
Conclusion: There is no significant difference in cardiac risk in patients who have undergone
vascular surgery within 6 months of a myocardial infarction compared with those who have had the
operation in the 6 to12 month time frame. Use of alpha-glutathione-S-transferase gives an
indication of the immediate state of hepatic function and should be used in addition to traditional
liver function tests to monitor hepatic function postoperatively.
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Introduction
Hepatic artery aneurysms (HAAs) are a rare but a clinically
important phenomenon. A review of the literature
between 1985 and 1995 showed that the HAA had sur-
passed splenic artery aneurysm (SAA) as the most fre-
quently reported visceral artery aneurysm [1]. This recent
trend is thought to be due to the proliferation of centres
performing invasive diagnostic and therapeutic hepatobil-
iary procedures, many of which have hepatic artery
pseudo-aneurysm formation as a recognised complica-
tion. The natural history of HAA is poorly understood,
however, it is suggested that mortality following sponta-
neous rupture is as high as 40% [2]. Statistics such as these
sanction an aggressive approach to the management of
the HAA, whenever detected.
It is recommended that aneurysmal repair be considered
in HAA larger than 2 cm [2]. In our case, the situation was
complicated by the fact that the patient had undergone a
large myocardial infarction (MI) 3 weeks prior to admis-
sion. The decisions to observe and to operate were both
high-risk options. The multidisciplinary team in conjunc-
tion with the patient and family had to decide if surgical
correction of the HAA was still a viable option and if so,
what if any window of the rehabilitation should be
allowed before attempting surgical repair.
The collaborative body of the American College of Cardi-
ology (ACC) and the American Heart Association (AHA)
stratify vascular surgery as high-risk surgery with a signifi-
cant probability (> 5%) of a perioperative cardiac event
fatal or otherwise. In addition, they recognise a previous
history of recent MI (within 3.6 months) in itself as a
major predictor of a perioperative cardiac event [3]. The
Cleveland Clinic and Bypass Angioplasty Revasculariza-
tion Investigation (BARI) retrospective studies, however,
demonstrated a low perioperative cardiac morbidity in
high-risk vascular patients who had previously undergone
percutaneous transluminal coronary angioplasty for car-
diac indications within 18 months [3]. Back and co-work-
ers [4] in their prospective study similarly observed a
reduction in the incidence of perioperative cardiac events
in patients with a recent (less than 2 years) history of cor-
onary angioplastic revascularisation.
Current ACC/AHA guidelines suggest that patients who
have undergone coronary revascularisation within the last
5 years and have remained asymptomatic are generally a
low cardiac risk. In this case, the patient underwent angi-
oplasty and stent insertion. The reduction in perioperative
cardiac risk afforded by coronary stenting in patients
undergoing vascular surgery has not been fully deter-
mined. It is thought to prolong the cardio-protective effect
of angioplasty. Very early surgery after coronary stenting
or surgery after stenting unsupported by an allied
antiplatelet schedule is associated with high incidences of
perioperative mortality and morbidity including stent
thrombosis, bleeding and embolisation [5,6]. It is sus-
pected that the perioperative cardio-protective effect of
coronary stenting is critically dependent upon the patient
having completed an antiplatelet regimen parallel to the
stenting process. It seems prudent for patients requiring
urgent high-risk surgery who have undergone pre-opera-
tive coronary stenting to complete their antiplatelet
course before surgical intervention is attempted.
In this case, it was decided that a previous MI should not
disqualify the patient from vascular repair in light of the
high-risk nature and unpredictability of the HAA and the
successful coronary revascularisation that had been per-
formed. This though raised the issue of when to schedule
surgery. Traditionally vascular surgery has been contrain-
dicated within 6 months of an MI due to inherent cardiac
instability leading to high rates of re-infarction and strat-
ospheric concomitant mortality. Such premises are based,
however, in old data which predate much of the rapid
thrombolysis, cardiac vascularisation and novel cardio-
tropic therapies currently in routine use. Recent studies
have shown no significant difference in cardiac risk in
patients who have undergone vascular surgery within 6
months of an MI compared with those who have had the
operation in the 6 to 12 month time frame [6].
Aneurysms of the hepatic artery propria, namely the sec-
tion of hepatic artery distal to the junction of the gas-
troduodenal and right gastric arteries, invariably require
vascular reconstruction if ischaemic liver injury is to be
avoided. In our patient, arteriotomy was performed with
subsequent interposition of reversed a long saphenous
vein graft. It is generally suggested, however, that in cases
where the gastroduodenal-pancreaticoduodenal artery
arcade is patent, then exclusion of the aneurysm is suffi-
cient with no real need for vascular reconstruction. (See
figures 1,2 and 3)
This is based on two premises. The first is that the liver
receives a significant quantity of blood (70%) from the
portal system and secondly, that the anastomotic arcade
between the coeliac axis and the superior mesenteric arter-
ies via the right gastric and gastroduodenal arteries should
meet any demands above this. Two fundamental princi-
ples, one anatomical and the other physiological, have
been overlooked. Although the hepatic artery supplies
only 30% by volume of blood perfusing the liver, it pro-
vides up to 60% of the oxygen metabolised by the organ.
This is because, unlike the blood within the portal system,
that of the hepatic artery is direct from the aorta and has
not bypassed the organs of the gastrointestinal tract. Sec-
ondly, the liver is a key homeostatic organ. The liver's
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autonomic regulation such that organ perfusion is closely
matched with the organ's metabolic demands. This is
achieved by varying the flow through the hepatic artery
rather than through the portal vein. It has been shown
that if the portal vein is clamped then blood flow through
the hepatic artery is increased such that oxygen supply to
the liver is almost unchanged. The converse, however, is
not true for the portal vein, if the hepatic artery is
clamped. Ligation of the common hepatic artery abro-
gates its regulatory function in hepatic perfusion and thus,
in certain physiological situations, oxygen demand may
fall short of supply leading to ischaemia. In the postpran-
dial setting, paracrine and endocrine factors cause a global
increase in blood flow throughout the coeliac and
mesenteric axes, thus ensuring adequate flow through the
gastroduodenal-pancreaticoduodenal conduit and ade-
quate perfusion of the liver in preparation for increased
metabolic activity following food ingestion.
In situations where the liver is acting in roles divorced
from its function as an accessory organ of the gastrointes-
tinal tract, such as during times of fasting or in roles such
as gluconeogenesis, protein deamination and metabolism
of endocrine and coagulation agents, there is no reaction-
Angiogram showing the patient's large hepatic artery aneurysm Figure 1
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ary increase in the flow through the coeliac-superior
mesenteric anastomoses and the liver is susceptible to
ischaemic injury if the hepatic artery has been excluded.
Where HAA repair has involved vascular reconstruction,
postoperative patency and definitive exclusion of the
aneurysm are commonly confirmed with abdominal arte-
rial duplex ultrasound. This alone, however, gives no indi-
cation as to the functional status of the liver nor does it
alert to any ischaemic injury suffered by the liver periop-
eratively. In addition, in the long term, if the graft were to
undergo progressive stenosis, the resultant effect on the
liver would be a crucial piece of information in devising
the next stage of the management plan.
We used alpha-glutathione-S-transferase (alpha-GST) in
conjunction with the conventional liver enzymes to assess
the extent of any hepatic ischaemic injury in the immedi-
ate and long-term postoperative period. Alpha-GST is a
highly useful marker of liver damage. It is found in high
concentrations within hepatocytes and is released follow-
ing hepatic injury and has a short plasma half-life
(approximately 90 minutes) [7]. Alpha-GST is superior to
the conventional liver functional enzymes as an index of
hepatic damage. The conventional hepatic biomarkers
have a long plasma half-life. Following hepatic ischaemic
injury, they remain elevated after alpha-GST has returned
to within normal limits. The short plasma half-life of
alpha-GST enables it to reliably reflect changes in hepato-
cellular status in the postoperative period. It is being
Angiogram showing the patient's large hepatic artery aneurysm Figure 2
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increasingly used in the transplant patient to assess the
degree of hepatic injury post-transplantation secondary to
either ischaemia or rejection. One trial observed that
monitoring alpha-GST in the transplant patient resulted
in improved patient care with an increase in graft survival,
a fall in mortality and morbidity and a lower frequency of
postoperative invasive diagnostic procedures up to 100
days postoperatively [8].
Conclusion
Traditionally, vascular surgery was contraindicated within
6 months of an acute coronary syndrome due to the high
risk of re-infarction and its associated mortality. However,
these assumptions were based upon studies conducted
before the introduction of clinical interventions such as
rapid thrombolysis, cardiac revascularisation and new car-
diotropic therapies which are routinely used nowadays.
More up-to-date studies have demonstrated that there is
no significant difference in cardiac risk in those patients
who have undergone vascular surgery within 6 months of
an MI.
In the long term, we intend to use both alpha-GST in addi-
tion to traditional hepatic biomarkers to assess postoper-
Computed tomography scan showing the hepatic artery aneurysm. Figure 3
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ative hepatic function and progress. The former gives an
indication of the immediate state of hepatic function,
while the latter reflects the long-term condition of the
liver. To the best of our knowledge, we report the first use
of this biochemical marker in the setting of visceral artery
reconstruction.
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